File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Clinical utility of serial analysis of circulating tumour cells for detection of minimal residual disease of metastatic nasopharyngeal carcinoma

TitleClinical utility of serial analysis of circulating tumour cells for detection of minimal residual disease of metastatic nasopharyngeal carcinoma
Authors
KeywordsCirculating Neoplastic Cell
Liquid Biopsy
Circulating Tumor DNA
Issue Date2020
PublisherSpringer Nature, published in association with Cancer Research UK. The Journal's web site is located at http://www.nature.com/bjc
Citation
British Journal of Cancer, 2020, v. 123, p. 114-125 How to Cite?
AbstractBackground: Nasopharyngeal carcinoma (NPC) is an important cancer in Hong Kong. We aim to utilise liquid biopsies for serial monitoring of disseminated NPC in patients to compare with PET-CT imaging in detection of minimal residual disease. Method: Prospective serial monitoring of liquid biopsies was performed for 21 metastatic patients. Circulating tumour cell (CTC) enrichment and characterisation was performed using a sized-based microfluidics CTC chip, enumerating by immunofluorescence staining, and using target-capture sequencing to determine blood mutation load. PET-CT scans were used to monitor NPC patients throughout their treatment according to EORTC guidelines. Results: The longitudinal molecular analysis of CTCs by enumeration or NGS mutational profiling findings provide supplementary information to the plasma EBV assay for disease progression for good responders. Strikingly, post-treatment CTC findings detected positive findings in 75% (6/8) of metastatic NPC patients showing complete response by imaging, thereby demonstrating more sensitive CTC detection of minimal residual disease. Positive baseline, post-treatment CTC, and longitudinal change of CTCs significantly associated with poorer progression-free survival by the Kaplan–Meier analysis. Conclusions: We show the potential usefulness of application of serial analysis in metastatic NPC of liquid biopsy CTCs, as a novel more sensitive biomarker for minimal residual disease, when compared with imaging.
Persistent Identifierhttp://hdl.handle.net/10722/284044
ISSN
2019 Impact Factor: 5.791
2015 SCImago Journal Rankings: 2.939
PubMed Central ID

 

DC FieldValueLanguage
dc.contributor.authorKo, JMY-
dc.contributor.authorVardhanabhuti, V-
dc.contributor.authorNg, WT-
dc.contributor.authorLam, KO-
dc.contributor.authorNgan, RKC-
dc.contributor.authorKwong, DLW-
dc.contributor.authorLee, VHF-
dc.contributor.authorLui, YH-
dc.contributor.authorYau, CC-
dc.contributor.authorKwan, CK-
dc.contributor.authorLi, WS-
dc.contributor.authorYau, S-
dc.contributor.authorGuo, C-
dc.contributor.authorChoi, SSA-
dc.contributor.authorLei, LC-
dc.contributor.authorChan, KCH-
dc.contributor.authorLam, CCS-
dc.contributor.authorChan, CKC-
dc.contributor.authorDai, W-
dc.contributor.authorKhong, PL-
dc.contributor.authorLung, ML-
dc.date.accessioned2020-07-20T05:55:39Z-
dc.date.available2020-07-20T05:55:39Z-
dc.date.issued2020-
dc.identifier.citationBritish Journal of Cancer, 2020, v. 123, p. 114-125-
dc.identifier.issn0007-0920-
dc.identifier.urihttp://hdl.handle.net/10722/284044-
dc.description.abstractBackground: Nasopharyngeal carcinoma (NPC) is an important cancer in Hong Kong. We aim to utilise liquid biopsies for serial monitoring of disseminated NPC in patients to compare with PET-CT imaging in detection of minimal residual disease. Method: Prospective serial monitoring of liquid biopsies was performed for 21 metastatic patients. Circulating tumour cell (CTC) enrichment and characterisation was performed using a sized-based microfluidics CTC chip, enumerating by immunofluorescence staining, and using target-capture sequencing to determine blood mutation load. PET-CT scans were used to monitor NPC patients throughout their treatment according to EORTC guidelines. Results: The longitudinal molecular analysis of CTCs by enumeration or NGS mutational profiling findings provide supplementary information to the plasma EBV assay for disease progression for good responders. Strikingly, post-treatment CTC findings detected positive findings in 75% (6/8) of metastatic NPC patients showing complete response by imaging, thereby demonstrating more sensitive CTC detection of minimal residual disease. Positive baseline, post-treatment CTC, and longitudinal change of CTCs significantly associated with poorer progression-free survival by the Kaplan–Meier analysis. Conclusions: We show the potential usefulness of application of serial analysis in metastatic NPC of liquid biopsy CTCs, as a novel more sensitive biomarker for minimal residual disease, when compared with imaging.-
dc.languageeng-
dc.publisherSpringer Nature, published in association with Cancer Research UK. The Journal's web site is located at http://www.nature.com/bjc-
dc.relation.ispartofBritish Journal of Cancer-
dc.subjectCirculating Neoplastic Cell-
dc.subjectLiquid Biopsy-
dc.subjectCirculating Tumor DNA-
dc.titleClinical utility of serial analysis of circulating tumour cells for detection of minimal residual disease of metastatic nasopharyngeal carcinoma-
dc.typeArticle-
dc.identifier.emailKo, JMY: joko@hku.hk-
dc.identifier.emailVardhanabhuti, V: varv@hku.hk-
dc.identifier.emailLam, KO: lamkaon@hku.hk-
dc.identifier.emailKwong, DLW: dlwkwong@hku.hk-
dc.identifier.emailLee, VHF: vhflee@hku.hk-
dc.identifier.emailChoi, SSA: ssachoi@HKUCC-COM.hku.hk-
dc.identifier.emailLei, LC: clei@HKUCC-COM.hku.hk-
dc.identifier.emailLam, CCS: lamcandy@hku.hk-
dc.identifier.emailChan, CKC: biocandy@hku.hk-
dc.identifier.emailDai, W: weidai2@hku.hk-
dc.identifier.emailKhong, PL: plkhong@hku.hk-
dc.identifier.emailLung, ML: mlilung@hku.hk-
dc.identifier.authorityKo, JMY=rp02011-
dc.identifier.authorityVardhanabhuti, V=rp01900-
dc.identifier.authorityLam, KO=rp01501-
dc.identifier.authorityKwong, DLW=rp00414-
dc.identifier.authorityLee, VHF=rp00264-
dc.identifier.authorityDai, W=rp02146-
dc.identifier.authorityKhong, PL=rp00467-
dc.identifier.authorityLung, ML=rp00300-
dc.description.naturelink_to_OA_fulltext-
dc.identifier.doi10.1038/s41416-020-0871-1-
dc.identifier.pmid32372027-
dc.identifier.pmcidPMC7341819-
dc.identifier.scopuseid_2-s2.0-85085152859-
dc.identifier.hkuros311248-
dc.identifier.volume123-
dc.identifier.spage114-
dc.identifier.epage125-
dc.publisher.placeUnited Kingdom-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats